Lisa Thelen
Impact in
-
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
-
- Cancer Genomics and Diagnostics
Papers in
-
- DNA Repair Mechanisms 2
- Epigenetics and DNA Methylation 1
- RNA Research and Splicing 1
- Oncology 3
- PARP inhibition in cancer therapy 2
- CAR-T cell therapy research 1
- Cancer-related Molecular Pathways 1
- Co-authors
- Hans Christian Reinhardt (4 shared papers)Felix Dietlein (2 shared papers)Uschi Leeser (2 shared papers)Winfried Edelmann (1 shared paper)Ron D. Jachimowicz (1 shared paper)Gero Knittel (2 shared papers)Mladen Jokić (1 shared paper)Lukas C. Heukamp (1 shared paper)
- Journals
- Cancers (1 paper)Pharmacology Research & Perspectives (1 paper)Trends in Genetics (1 paper)PLoS ONE (1 paper)Cancer Discovery (1 paper)
- Partner nations
- GermanyTaiwanUnited States
In The Last Decade
Lisa Thelen
5 papers receiving 289 citations
Peers
Comparison fields: 5 of 49
- Oncology 139
- Cancer Research 59
- Molecular Biology 232
- Genetics 24
- Pathology and Forensic Medicine 39
Countries citing papers authored by Lisa Thelen
This map shows the geographic impact of Lisa Thelen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Thelen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Thelen more than expected).
Fields of papers citing papers by Lisa Thelen
This network shows the impact of papers produced by Lisa Thelen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Thelen. The network helps show where Lisa Thelen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lisa Thelen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 194 | |
| 2 | 2014 | 53 | |
| 3 | 2015 | 29 | |
| 4 | 2016 | 7 | |
| 5 | 2020 | 7 |
About Lisa Thelen
Lisa Thelen is a scholar working on Molecular Biology, Oncology, Genetics, Pathology and Forensic Medicine and Hematology, having authored 5 papers that have together received 290 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (2 papers), DNA Repair Mechanisms (2 papers), Epigenetics and DNA Methylation (1 paper), Lymphoma Diagnosis and Treatment (1 paper), CAR-T cell therapy research (1 paper), RNA Research and Splicing (1 paper), Blood Coagulation and Thrombosis Mechanisms (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Oncology (139 citations), Cancer Research (59 citations), Molecular Biology (232 citations), Genetics (24 citations) and Pathology and Forensic Medicine (39 citations). Lisa Thelen has collaborated with scholars based in Germany, Taiwan and United States. Frequent co-authors include Hans Christian Reinhardt, Felix Dietlein, Uschi Leeser, Winfried Edelmann, Ron D. Jachimowicz, Gero Knittel, Mladen Jokić, Lukas C. Heukamp, Janine Altmueller and Martin Peifer. Their work appears in journals such as Cancers, Pharmacology Research & Perspectives, Trends in Genetics, PLoS ONE and Cancer Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.